Clinical Trial Update: A Dose-range Study of the Safety and Efficacy of Treatment in Adult Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate [Phase 2]

View source ↗

Summary

A Phase 2 dose-range study in adults with rheumatoid arthritis who have an inadequate response to methotrexate has completed, evaluating the safety and efficacy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Snippet

Sponsor: SynAct Pharma Aps | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED